{"release":{"schemaVersion":"maha-epistemic-release/1.0","releaseId":"epirelease_e262e328902e4be18ae9f8b90a398db1","releaseKind":"initial","status":"active","recordId":"urn:maha:record:cell-line-versus-primary-cell-evidence","domainSlug":"synthetic-biology","targetSha256":"sha256:6b6b99f6540b8e46e2895fcacf978dc6cea7ca8688fe377cbce0201b6957b54d","canonicalPath":"/knowledge/synthetic-biology/comparisons/cell-line-versus-primary-cell-evidence","canonicalVersion":"1.0.0","supersedesReleaseId":null,"approvals":[{"scope":"boundary-adequacy","reviewId":"epireview_ccee7cdec3dd433889f920c75c38046f","reviewSha256":"sha256:2998170b9e283469802e52ea3b34b829ed3ec02853b173200ff4c01e0aa29bc7","reviewedAt":"2026-08-30T16:02:03.530Z","reviewerKind":"internal-editorial","reviewMethod":"Each criterion is recomputed from the exact record, its inspected alignment audit, source identity, exact locator, rights basis, claim scope, boundary, uncertainty, replication status, prohibited inferences, and revision digest."},{"scope":"domain-fidelity","reviewId":"epireview_5fdcd3b7ad3b4a2b87ed9318a5fba4c8","reviewSha256":"sha256:9bdd643f80c16b3b176262588c5f1f612c49ba50e7e8c2c76c17b1cb15b421ae","reviewedAt":"2026-08-30T16:02:03.467Z","reviewerKind":"internal-editorial","reviewMethod":"Each criterion is recomputed from the exact record, its inspected alignment audit, source identity, exact locator, rights basis, claim scope, boundary, uncertainty, replication status, prohibited inferences, and revision digest."},{"scope":"rights-and-locator","reviewId":"epireview_21dfd568133541a2977481dc3fbe5f7d","reviewSha256":"sha256:407d2d3184ec370df0fdecd362ba400afe379e2842fc766f313e8efb284df59b","reviewedAt":"2026-08-30T16:02:03.603Z","reviewerKind":"internal-editorial","reviewMethod":"Each criterion is recomputed from the exact record, its inspected alignment audit, source identity, exact locator, rights basis, claim scope, boundary, uncertainty, replication status, prohibited inferences, and revision digest."},{"scope":"source-fidelity","reviewId":"epireview_0eb5c7ad76674d83b817f2c4a3a41b3c","reviewSha256":"sha256:f66c5427501c26f73de7a99a2a073e261065c3bc9b8c3e1da18953f1f5f56038","reviewedAt":"2026-08-30T16:02:03.350Z","reviewerKind":"internal-editorial","reviewMethod":"Each criterion is recomputed from the exact record, its inspected alignment audit, source identity, exact locator, rights basis, claim scope, boundary, uncertainty, replication status, prohibited inferences, and revision digest."}],"assuranceTier":"internally-reviewed-canonical","releaseAuthority":{"authoritySha256":"sha256:2a0161a3927ae8366af44bda6671b5249802843ff3895dc292c90e5466b88609","attribution":"withheld-by-consent"},"publicChangeSummary":"Initial canonical publication under the disclosed exact-revision internal editorial tier.","recordSha256":"sha256:d3a5240fcb9425c41d5687b231e1d31a9194ad969d066dbd1e0a8d4772c3a392","gateDecision":{"reasons":[],"recordId":"urn:maha:record:cell-line-versus-primary-cell-evidence","publicEligible":true,"evaluatedAgainst":"maha-epistemic/1.0"},"releasedAt":"2026-08-30T16:02:55.045Z","releaseSha256":"sha256:fbd30b96a226f9640a1fe0e34c0e51a6dfb84d8751b463fe24d9d44e953b48b3","withdrawal":null},"provenance":{"schemaVersion":"maha-epistemic/1.0","evidencePolicyVersion":"mps/0.1","recordId":"urn:maha:record:cell-line-versus-primary-cell-evidence","canonicalPath":"/knowledge/synthetic-biology/comparisons/cell-line-versus-primary-cell-evidence","contentHash":"sha256:d3a5240fcb9425c41d5687b231e1d31a9194ad969d066dbd1e0a8d4772c3a392","generatedAt":"2026-08-30T16:02:55.045Z","publicationDecision":{"recordId":"urn:maha:record:cell-line-versus-primary-cell-evidence","publicEligible":true,"evaluatedAgainst":"maha-epistemic/1.0","reasons":[]},"claims":[{"id":"urn:maha:claim:cell-line-versus-primary-cell-evidence","scope":"The constructs, biological systems, protocols, assays, datasets, and comparisons reported in CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity.","boundary":"Results from a transformed line cannot be silently relabeled as performance in primary cells, and donor variation remains a separate uncertainty source.","claimKind":"empirical-claim","sourceIds":["source-lazzarotto-change-seq-2020"],"statement":"The cited study measures and compares off-target activity and genomic context in therapeutically relevant loci and primary human T-cell experiments.","replication":{"asOfDate":"2026-08-24","assessment":"This candidate records one bounded source package. Independent replications and contradictory results must be compiled separately before evidence maturity is upgraded.","independentReplicationCount":null},"uncertainty":{"kind":"qualitative","statement":"There is no universal effect estimate for this method; numerical results remain attached to the source experiment, biological system, assay, and analysis choices."},"evidenceMaturity":"single-study"}],"sources":[{"id":"source-lazzarotto-change-seq-2020","url":"https://www.nature.com/articles/s41587-020-0555-7","title":"CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity","rights":{"note":"Maha paraphrases the source-level result and links to the version of record; no article passage is reproduced.","basis":"citation-with-paraphrase","quotationUsed":false},"authors":["Christopher R. Lazzarotto","Nhu T. Nguyen","J. A. Tangprasertchai","S. C. Malagon-Lopez","et al."],"boundary":"In-vitro nomination is not identical to editing frequency or biological consequence in a treated cell population or organism.","publisher":"Nature Biotechnology","establishes":"The study develops an in-vitro circularized-DNA assay for Cas9 activity and compares nominations with cellular activity and genomic context for specified targets.","identifiers":[{"value":"10.1038/s41587-020-0555-7","scheme":"doi"}],"publishedAt":"2020-06-22","exactLocator":"Abstract; Figures 1–6; Methods; datasets PRJNA625995 and GSE149295.","conflictsOfInterest":"The article declares patent and company relationships involving genome-editing assays and therapeutics."}],"reviewEvents":[{"reviewId":"epireview_0eb5c7ad76674d83b817f2c4a3a41b3c","scope":"source-fidelity","targetSha256":"sha256:6b6b99f6540b8e46e2895fcacf978dc6cea7ca8688fe377cbce0201b6957b54d","reviewedAt":"2026-08-30T16:02:03.350Z","verdict":"approve","supersedesReviewId":null},{"reviewId":"epireview_5fdcd3b7ad3b4a2b87ed9318a5fba4c8","scope":"domain-fidelity","targetSha256":"sha256:6b6b99f6540b8e46e2895fcacf978dc6cea7ca8688fe377cbce0201b6957b54d","reviewedAt":"2026-08-30T16:02:03.467Z","verdict":"approve","supersedesReviewId":null},{"reviewId":"epireview_ccee7cdec3dd433889f920c75c38046f","scope":"boundary-adequacy","targetSha256":"sha256:6b6b99f6540b8e46e2895fcacf978dc6cea7ca8688fe377cbce0201b6957b54d","reviewedAt":"2026-08-30T16:02:03.530Z","verdict":"approve","supersedesReviewId":null},{"reviewId":"epireview_21dfd568133541a2977481dc3fbe5f7d","scope":"rights-and-locator","targetSha256":"sha256:6b6b99f6540b8e46e2895fcacf978dc6cea7ca8688fe377cbce0201b6957b54d","reviewedAt":"2026-08-30T16:02:03.603Z","verdict":"approve","supersedesReviewId":null}]},"privacyBoundary":"Operational actor fingerprints, bearer credentials, private reviewer profiles, affiliations, conflicts, and non-consented authority identity fields are excluded."}